These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 29603092

  • 1. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Dec; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 3. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M, Jäkel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM.
    Mol Neurobiol; 2016 Jul 10; 53(5):2894-2899. PubMed ID: 25895659
    [Abstract] [Full Text] [Related]

  • 5. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov 10; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 6. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.
    PLoS One; 2015 Nov 10; 10(10):e0139233. PubMed ID: 26426747
    [Abstract] [Full Text] [Related]

  • 7. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F, Liu X, Li F, Liu H, Sun L, Zhao K.
    Mol Neurobiol; 2021 Jul 10; 58(7):3084-3094. PubMed ID: 33629272
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Jul 10; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 9. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
    Li F, Xie XY, Sui XF, Wang P, Chen Z, Zhang JB.
    Neuroscience; 2020 Apr 15; 432():240-246. PubMed ID: 32135232
    [Abstract] [Full Text] [Related]

  • 10. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S, Reddy PH.
    Biochim Biophys Acta; 2016 Sep 15; 1862(9):1617-27. PubMed ID: 27264337
    [Abstract] [Full Text] [Related]

  • 11. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 15; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
    Lv Z, Hu L, Yang Y, Zhang K, Sun Z, Zhang J, Zhang L, Hao Y.
    Metab Brain Dis; 2018 Oct 15; 33(5):1711-1720. PubMed ID: 29961914
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B, Montanino C, Oliva M, Bonavita S, Di Onofrio V, Coppola C.
    Mol Neurobiol; 2020 Nov 15; 57(11):4408-4416. PubMed ID: 32737762
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
    Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, Rohrer JD, Tartaglia MC, Robertson J, Genetic FTD Initiative (GENFI).
    J Neurol Neurosurg Psychiatry; 2018 Aug 15; 89(8):851-858. PubMed ID: 29434051
    [Abstract] [Full Text] [Related]

  • 15. Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy.
    Chia SY, Vipin A, Ng KP, Tu H, Bommakanti A, Wang BZ, Tan YJ, Zailan FZ, Ng ASL, Ling SC, Okamura K, Tan EK, Kandiah N, Zeng L.
    J Alzheimers Dis; 2022 Aug 15; 88(4):1567-1584. PubMed ID: 35811521
    [Abstract] [Full Text] [Related]

  • 16. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis.
    Chen H, Zhou Y, Wang ZY, Yan BX, Zhou WF, Wang TT, Zheng M, Man XY.
    Sex Transm Infect; 2019 Jun 15; 95(4):246-250. PubMed ID: 30926713
    [Abstract] [Full Text] [Related]

  • 17. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
    Tan YJ, Wong BYX, Vaidyanathan R, Sreejith S, Chia SY, Kandiah N, Ng ASL, Zeng L.
    J Alzheimers Dis Rep; 2021 Jun 15; 5(1):805-813. PubMed ID: 34870106
    [Abstract] [Full Text] [Related]

  • 18. Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
    Riancho J, Santurtun A, Sánchez-Juan P.
    Methods Mol Biol; 2019 Jun 15; 2044():343-352. PubMed ID: 31432424
    [Abstract] [Full Text] [Related]

  • 19. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
    Sarkar S, Engler-Chiurazzi EB, Cavendish JZ, Povroznik JM, Russell AE, Quintana DD, Mathers PH, Simpkins JW.
    Brain Res; 2019 Oct 15; 1721():146327. PubMed ID: 31295467
    [Abstract] [Full Text] [Related]

  • 20. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
    Herrera-Espejo S, Santos-Zorrozua B, Álvarez-González P, Lopez-Lopez E, Garcia-Orad Á.
    Mol Neurobiol; 2019 Dec 15; 56(12):8376-8391. PubMed ID: 31240600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.